Related Experiment Video
Updated: Sep 5, 2025

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD
Published on: September 13, 2018
[Sodium-chlorine difference as a prognostic predictor in adult patients diagnosed with COVID-19]
Francisco Javier Núñez-Martínez1, Rafael Luna-Montalbán2, Karla Orozco-Juárez3
1Instituto Mexicano del Seguro Social, Hospital de Especialidades No.1 del Bajío, Servicio de Medicina Interna. León, Guanajuato, México.
Insights
The sodium-chloride difference in COVID-19 patients did not predict mortality or mechanical ventilation needs. However, a difference <31 mEq/L was linked to acute kidney injury and longer hospital stays.
Area of Science:
- Critical Care Medicine
- Nephrology
- Infectious Diseases
Background:
- Hyperchloremia is linked to increased morbidity and mortality in critically ill patients.
- The sodium-chloride difference can reflect relative and absolute hyperchloremia.
Purpose of the Study:
- To determine if a sodium-chloride difference <31 mEq/L predicts 28-day mortality in COVID-19 patients.
- To assess the association between this difference and the need for mechanical ventilation, acute kidney injury (AKI), and hospital stay duration.
Main Methods:
- Retrospective, descriptive, analytical longitudinal cohort study.
- Included 722 COVID-19 patients (RT-PCR positive) aged over 16.
- Measured sodium-chloride difference 24-48 hours post-admission.
Main Results:
- A sodium-chloride difference <31 mEq/L did not correlate with increased 28-day mortality (OR: 1.35) or mechanical ventilation (OR: 1.19).
- This difference was significantly associated with a higher risk of AKI (OR: 2.04) and longer hospital stays.
Conclusions:
- The sodium-chloride difference <31 mEq/L is not a predictor of mortality or mechanical ventilation in COVID-19 patients.
- This electrolyte imbalance is associated with increased risk of AKI and prolonged hospitalization in COVID-19 patients.
Background:
Hyperchloremia has been associated with a greater presence of morbidity and mortality, mainly described in critically ill patients, this may be relative and absolute, which could be reflected in the sodium-chloride difference.
Objective:
The primary objective was to determine whether the sodium-chloride difference <31 mEq/L measured 24-48 hours after admission is a predictor of 28-day mortality in patients with COVID-19, and as secondary objectives to identify whether it is associated with higher requirement for invasive mechanical ventilation, presence of acute kidney injury and longer hospital stay.
Material And Methods:
Retrospective, descriptive and analytical longitudinal cohort study, was done including all consecutive patients older than 16 years of any gender, admitted to the UMAE from March 1, 2020 to March 2021, which present a diagnosis of COVID-19 with RT-PCR test for SARS-CoV-2 positive.
Results:
A total of 722 patients were included, the difference sodium-chloride < 31 mEq/L is not associated with an increased risk of death at 28 days (p = 1.172, OR: 1.35; 95%CI, 0.87-2.08) or requirement of mechanical ventilation (p = 0.47, OR: 1.19; 95%CI, 0.76-1.86), but is associated with a higher risk of AKI (p < 0.05, OR: 2.04; 95%CI, 1.33- 3.14) and longer hospital stay (p < 0.05).
Conclusions:
the sodium-chloride difference < 31 mEq/L in the first hours of admission is associated with a higher risk of presenting acute kidney injury during hospital stay in patients with COVID-19, as well as a longer hospital stay.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Related Concept Videos
Pneumonia III: Complications and Assessment
Roles of Electrolytes: Chloride and Bicarbonate
Conditions such as hypochloremia can arise from insufficient chloride reabsorption by the kidneys, often compounded by extended bouts of diarrhea, vomiting,...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Heart Failure VI: Adjunct Therapies
Acute Coronary Syndrome III: Diagnostic Studies